Here are four things to know.
1. Dr. Fitzgerald’s resignation came less than 48 hours after Politico published a report revealing she invested in tobacco and drug company stock while leading the CDC.
2. CDC COO Sherri Berger sent an agencywide email naming Ms. Schuchat acting director just three hours after news of Dr. Fitzgerald’s resignation went public, according to The Washington Post.
3. Dr. Schuchat has served as the agency’s principal deputy director since September 2015. She also previously served as acting CDC director from January 2017, when President Donald Trump took office, to July 2017, when he appointed Dr. Fitzgerald to the role.
4. Dr. Schuchat joined the CDC in 1988, where she’s overseen the agency’s vaccine and bacteria prevention programs, among other initiatives.
More articles on leadership and management:
ACA repeal and replace not discussed during Trump’s State of the Union
Mike Harbour: 5 actions leaders can take to decrease physician burnout
6 healthcare trends for leaders to follow in 2018
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.